» Articles » PMID: 24265260

MR Imaging of Urinary Bladder Cancer for T-staging: a Review and a Pictorial Essay of Diffusion-weighted Imaging

Overview
Date 2013 Nov 23
PMID 24265260
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment decisions for bladder cancer patients are mainly based on the depth of bladder wall invasion by the tumor. In this article, we review the conventional MRI and exhibit a recently emerged diffusion-weighted imaging (DWI) of urinary bladder cancer for T-staging. We discuss limitations of conventional MRI, scanning protocols of DWI, normal pelvic findings on DWI, determination of T-stage using DWI, and pitfalls of DWI. DWI provides high contrast between bladder cancer and background tissue because the cancer shows markedly high SI. DWI has high sensitivity for detecting the stalk seen in stage Ta or T1. An inflammatory change or fibrosis surrounding the tumor mimics the invasion of bladder cancer on T2-weighted imaging or enhanced MRI and could lead to over-staging, but DWI could differentiate them clearly because these benign changes do not show high SI on DWI. DWI is also useful for detecting ureteral, urethral, and prostatic extension by means of the urethra. DWI provides more accurate information on the extent of bladder cancer and contributes to determination of the treatment strategy.

Citing Articles

Comparative analysis of image quality and diagnostic performance among SS-EPI, MS-EPI, and rFOV DWI in bladder cancer.

Takeuchi M, Higaki A, Kojima Y, Ono K, Maruhisa T, Yokoyama T Jpn J Radiol. 2024; .

PMID: 39548050 DOI: 10.1007/s11604-024-01694-1.


Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.

James N, Pirrie S, Liu W, Catto J, Jefferson K, Patel P Health Technol Assess. 2024; 28(42):1-65.

PMID: 39246267 PMC: 11403381. DOI: 10.3310/DEHT5407.


Pictorial review of the diagnosis of muscle-invasive bladder cancer using vesical imaging-reporting and data system (VI-RADS).

Takeuchi M, Tamada T, Higaki A, Kojima Y, Ueno Y, Yamamoto A Abdom Radiol (NY). 2024; 49(12):4463-4480.

PMID: 38900320 DOI: 10.1007/s00261-024-04424-3.


Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies.

Akin O, Lema-Dopico A, Paudyal R, Konar A, Chenevert T, Malyarenko D Cancers (Basel). 2023; 15(22).

PMID: 38001728 PMC: 10670574. DOI: 10.3390/cancers15225468.


A machine learning model based on MRI for the preoperative prediction of bladder cancer invasion depth.

Chen G, Fan X, Wang T, Zhang E, Shao J, Chen S Eur Radiol. 2023; 33(12):8821-8832.

PMID: 37470826 DOI: 10.1007/s00330-023-09960-y.